New Journey Health Technology Group Co.,LTD (SHE:002219)

China flag China · Delayed Price · Currency is CNY
2.500
+0.120 (5.04%)
At close: Mar 6, 2026
-9.09%
Market Cap 8.44B
Revenue (ttm) 3.11B
Net Income (ttm) 19.58M
Shares Out 3.38B
EPS (ttm) 0.01
PE Ratio 431.22
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 182,750,400
Average Volume 110,115,832
Open 2.370
Previous Close 2.380
Day's Range 2.360 - 2.600
52-Week Range 2.030 - 2.970
Beta 0.56
RSI 54.98
Earnings Date Apr 3, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other pro... [Read more]

Sector Healthcare
Founded 2001
Employees 9,097
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002219
Full Company Profile

Financial Performance

In 2024, SHE:002219's revenue was 3.80 billion, a decrease of -2.95% compared to the previous year's 3.91 billion. Earnings were 114.77 million, an increase of 296.13%.

Financial Statements

News

There is no news available yet.